Ｋｒｉｎｇｌｅ Ｐｈａｒｍａ， Ｉｎｃ．
クリングルファーマ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4884
FY2024 · 2025-09-30
| Gross margin | 100.0% |
| Operating margin | -1259.4% |
| Net margin | -1268.8% |
| Return on equity | — |
| Return on assets | -44.1% |
| Revenue growth (YoY) | -9.8% |
| EPS (basic) | ¥-133.92 |
| EPS growth (YoY) | — |
| Current ratio | 18.80x |
| Equity ratio | 61.5% |
| Book value / share | ¥182.3 |
| Free cash flow | — |